Table 2.
Characteristic | Regimen 1A (n = 45) | Regimen 1B (n = 47) | P |
---|---|---|---|
Age, years | |||
< 10 | 24 | 24 | N/S |
≥ 10 | 21 | 23 | |
Sex | |||
Male | 18 | 33 | .004 |
Female | 27 | 14 | |
Histology | |||
Alveolar | 22 | 27 | N/S |
Embryonal | 15 | 16 | |
Other | 8 | 4 | |
Primary site (at original diagnosis)* | |||
Favorable | 6 | 6 | N/S |
Unfavorable | 39 | 41 | |
Size (largest target lesion), cm | |||
≥ 5 | 12 | 16 | N/S |
< 5 | 33 | 31 | |
Recurrence† | |||
Local | 22 | 20 | N/S |
Regional lymph nodes | 10 | 11 | |
Bone marrow/bone | 11 | 9 | |
Other distant sites | 20 | 23 |
Abbreviation: N/S, not significant.
Favorable sites: nonparameningeal head and neck, nonbladder/prostate genitourinary and biliary; unfavorable sites: all others.
Numbers indicate distribution of sites of recurrence. Patients may have had more than one site of recurrence.